Home
Browse
Search
Statistics
About
Usage
PMID: 25522986
Zannis VI, Fotakis P, Koukos G, Kardassis D, Ehnholm C, Jauhiainen M, Chroni A
HDL biogenesis, remodeling, and catabolism.
Handb Exp Pharmacol. 2015;224:53-111. doi: 10.1007/978-3-319-09665-0_2.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
50
ABCA1 p.Trp590Ser
X
ABCA1 p.Trp590Ser 25522986:50:33
status:
NEW
view ABCA1 p.Trp590Ser details
A notable exemption is the ABCA1[
W590S
] mutant which cross-linked stronger to apoA-I than to WT ABCA1 but had diminished capacity to promote cholesterol efflux and to promote formation of HDL (Bodzioch et al. 1999; Fitzgerald et al. 2001, 2002).
Login to comment
76
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:76:188
status:
NEW
view ABCA1 p.Leu222Ala details
Adenovirus-mediated gene transfer of these mutants in apoA-I / x apoE / mice (Fotakis et al. 2013a, b) showed that compared to the WT apoA-I, the expression of an apoA-I[L218A/L219A/V221A/
L222A
] mutant decreased plasma cholesterol, apoA-I, and HDL cholesterol levels and generated preb2;- and b1;4 HDL subpopulations (Fotakis et al. 2013a) (Table 1 and Fig. 3a-g).
Login to comment
77
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:77:144
status:
NEW
view ABCA1 p.Leu222Ala details
To eliminate the involvement of apoE in the generation of apoE-containing HDL particles (Kypreos and Zannis 2007), the apoA-I[L218A/L219A/V221A/
L222A
] mutant was expressed in apoA-I / x apoE / mice via adenovirus-mediated gene transfer (Fotakis et al. 2013a).
Login to comment
81
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:81:382
status:
NEW
view ABCA1 p.Leu222Ala details
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:81:532
status:
NEW
view ABCA1 p.Leu222Ala details
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:81:617
status:
NEW
view ABCA1 p.Leu222Ala details
Table 1 Plasma lipids and hepatic mRNA levels of apoA-I / or apoA-I / x apoE / mice expressing WT and mutant forms of apoA-I in the presence and absence of LCAT as indicated Protein expressed Total cholesterol (mg/dL) Triglycerides (mg/dL) Relative apoA-I mRNA (%) apoA-I plasma levels (mg/dL) WT apoA-I in apoA-I / mice 278 74 78 24 100 26 260 40 apoA-I[L218A/L219A/V221A/
L222A
] in apoA-I / mice 45 14 50 20 95 24 41 5 WT apoA-I in apoA-I / x apoE / mice 1,343 104 294 129 100 13 - apoA-I[L218A/L219A/V221A/
L222A
] in apoA-I / x apoE / mice 778 52 18 2 92 23 - apoA-I[L218A/L219A/V221A/
L222A
] plus LCAT in apoA-I / x apoE / mice 754 122 37 10 90 3 - Fig. 3 (a-g) ApoA-I mutations and their effect on the HDL phenotypes.
Login to comment
82
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:82:130
status:
NEW
view ABCA1 p.Leu222Ala details
Analysis of plasma of apoA-I / x apoE / mice infected with adenoviruses expressing the WT apoA-I or the apoA-I [L218A/L219A/V221A/
L222A
] mutant, as indicated, by density gradient ultracentrifugation and SDS-PAGE (a, e).
Login to comment
83
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:83:127
status:
NEW
view ABCA1 p.Leu222Ala details
EM analysis of HDL fractions 6-7 obtained from apoA-I / x apoE / mice expressing the WT apoA-I or the apoA-I[L218A/L219A/V221A/
L222A
] mutant, as indicated, following density gradient ultracentrifugation of plasma (b, f).
Login to comment
85
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:85:152
status:
NEW
view ABCA1 p.Leu222Ala details
Two-dimensional gel electrophoresis of plasma of apoA-I / x apoE / mice infected with adenoviruses expressing WT apoA-I or the apoA-I[L218A/L219A/V221A/
L222A
] mutant, as indicated (d, g) These particles may originate from apoB-48 containing lipoproteins that are found in the HDL fractions (Fig. 3c).
Login to comment
88
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:88:46
status:
NEW
view ABCA1 p.Leu222Ala details
Co-expression of the apoA-I[L218A/L219A/V221A/
L222A
] mutant and human LCAT in apoA-I / x apoE / mice did not correct the plasma apoA-I levels and did not correct the aberrant HDL phenotype.
Login to comment
92
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:92:55
status:
NEW
view ABCA1 p.Leu222Ala details
The phenotype produced by the apoA-I[L218A/L219A/V221A/
L222A
] mutations is distinct from all previously described phenotypes and cannot be corrected by overexpression of LCAT.
Login to comment
94
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:94:137
status:
NEW
view ABCA1 p.Leu222Ala details
Although other interpretations are possible, the in vivo and in vitro data suggest that the interaction of the apoA-I [L218A/L219A/V221A/
L222A
] mutant with ABCA1 results in defective lipidation of apoA-I that leads to the generation of preb2;-HDL particles that are not a good substrate for LCAT.
Login to comment
99
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:99:153
status:
NEW
view ABCA1 p.Leu222Ala details
The phenotype generated by the expression of the apoA-I[F225A/V227A/ F229A/L230A] mutant was similar to that obtained with the apoA-I[L218A/ L219A/V221A/
L222A
] mutant.
Login to comment
421
ABCA1 p.Leu222Ala
X
ABCA1 p.Leu222Ala 25522986:421:95
status:
NEW
view ABCA1 p.Leu222Ala details
ApoA-I mutants with defective C-terminal apoA-I[Ɗ(185-243)] and apoA-I[L218A/L219A/V221A/
L222A
] had 80 % decreased specific binding and 90 % decreased specific transport by aortic endothelial cells.
Login to comment